Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Iqvia Holdings Inc    IQV

IQVIA HOLDINGS INC

(IQV)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/20/2019 05/21/2019 05/22/2019 05/23/2019 05/24/2019 Date
133.67(c) 134.57(c) 134.82(c) 134.44(c) 136.38 Last
1 022 199 699 918 1 246 630 1 354 995 984 085 Volume
0.00% +0.67% +0.19% -0.28% +1.44% Change
More quotes
Financials (USD)
Sales 2019 11 012 M
EBIT 2019 2 076 M
Net income 2019 464 M
Debt 2019 9 483 M
Yield 2019 -
Sales 2020 11 747 M
EBIT 2020 2 269 M
Net income 2020 681 M
Debt 2020 9 109 M
Yield 2020 -
P/E ratio 2019 56,59
P/E ratio 2020 40,10
EV / Sales2019 3,27x
EV / Sales2020 3,03x
Capitalization 26 517 M
More Financials
Company
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial... 
More about the company
Surperformance© ratings of Iqvia Holdings Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on IQVIA HOLDINGS INC
05/23IQVIA : to Participate in William Blair Growth Stock Conference on June 5, 2019
BU
05/14IQVIA : to Host Financial Analyst and Investor Conference on June 18, 2019
BU
05/13IQVIA : Launches IQVIA : MedTech Dedicated to Medical Device and Diagnostics Ind..
BU
05/10IQVIA HOLDINGS INC. : Entry into a Material Definitive Agreement, Creation of a ..
AQ
05/09IQVIA : ™ Institute for Human Data Science Releases 2019 Medicines Report ..
BU
05/07IQVIA HOLDINGS INC. : Entry into a Material Definitive Agreement, Other Events, ..
AQ
05/07IQVIA : Announces Pricing of Offering of Senior Notes
BU
05/07IQVIA : Announces Offering of Senior Notes
BU
05/02IQVIA : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
05/01IQVIA : 1Q Earnings Snapshot
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
05/21Global chemical firms urged to source responsibly after lethal China blast - ..
RE
05/15GILEAD SCIENCES : Novartis gets approval to sell Kymriah in Japan for $306,000
RE
05/13REGENERON PHARMACEUTICALS : Says FDA Approves Eylea Injection for All Diabetic R..
DJ
05/10PATRICK THOMAS : Biotech Industry Woos Talent With Top Pay -- WSJ
DJ
05/09PATRICK THOMAS : Biotech Is Place to Be for Top Salaries
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart IQVIA HOLDINGS INC
Duration : Period :
Iqvia Holdings Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 159 $
Spread / Average Target 18%
EPS Revisions
Managers
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
Jim Berkshire Senior Vice President-Business Operations
Michael R. McDonnell Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
Margaret Keegan President-Clinical Operations
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC15.73%26 517
LONZA GROUP23.05%23 240
CELLTRION, INC.--.--%19 480
INCYTE CORPORATION26.59%17 262
EXACT SCIENCES CORPORATION48.97%12 139
SEATTLE GENETICS, INC.20.07%10 974